Third Eye(TM) Retroscope(TM) Improved Polyp Detection by Thirteen Percent
SAN DIEGO, May 21 /PRNewswire/ -- At the Digestive Disease Week conference in San Diego (DDW 2008), world-renowned gastroenterologist Jerome D. Waye, MD presented clinical results from a multi-institutional study which evaluated the efficacy of the Third Eye(TM) Retroscope(TM), a new device that improves the ability of physicians to visualize abnormalities in the colon.
The study showed that the Third Eye Retroscope, when used in combination with a standard colonoscope, detects a significantly higher number of adenomas and other polyps than the colonoscope alone. The Third Eye Retroscope has been cleared for use in the U.S. by the Food and Drug Administration (FDA).
"It is quite an ingenious device," said Dr. Waye. "The technology behind it is amazing."
Colorectal cancer is the second greatest cause of cancer death in the U.S. However, most cancers of the lower gastrointestinal (GI) tract can be completely cured if they are detected early. Even more cases can be completely prevented if pre-cancerous polyps can be removed before they become malignant.
Principal Investigator Dr. Waye, of Mount Sinai Hospital in New York, presented the study results yesterday afternoon in front of physicians and other industry professionals during the conference, being held at the San Diego Convention Center. The multi-center study has evaluated 214 patients to date at eight sites across the U.S. During the study, patients were examined using a Third Eye Retroscope in combination with a standard colonoscope. The abstract of the study by Dr. Waye and his co-authors was accepted for publication by the DDW review panel of the American Society for Gastrointestinal Endoscopy (ASGE). Dr. Waye was also invited to present the abstract during this week's annual conference.
"Colonoscopy is currently considered the best method for colorectal
cancer screening. However, it is well
|SOURCE Avantis Medical Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved